Authors:
Wu, CY
Wang, X
Gadina, M
O'Shea, JJ
Presky, DH
Magram, J
Citation: Cy. Wu et al., IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites, J IMMUNOL, 165(11), 2000, pp. 6221-6228
Authors:
Rogge, L
Papi, A
Presky, DH
Biffi, M
Minetti, LJ
Miotto, D
Agostini, C
Semenzato, G
Fabbri, LM
Sinigaglia, F
Citation: L. Rogge et al., Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo, J IMMUNOL, 162(7), 1999, pp. 3926-3932
Authors:
Wang, X
Wilkinson, VL
Podlaski, FJ
Wu, CY
Stern, AS
Presky, DH
Magram, J
Citation: X. Wang et al., Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits, EUR J IMMUN, 29(6), 1999, pp. 2007-2013
Authors:
Rakhit, A
Yeon, MM
Ferrante, J
Fettner, S
Nadeau, R
Motzer, R
Bukowski, R
Carvajal, DM
Wilkinson, VL
Presky, DH
Magram, J
Gately, MK
Citation: A. Rakhit et al., Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice, CLIN PHARM, 65(6), 1999, pp. 615-629
Authors:
Rogge, L
D'Ambrosio, D
Biffi, M
Penna, G
Minetti, LJ
Presky, DH
Adorini, L
Sinigaglia, F
Citation: L. Rogge et al., The role of stat4 in species-specific regulation of Th cell development bytype I IFNs, J IMMUNOL, 161(12), 1998, pp. 6567-6574